Altered insula connectivity under MDMA
This within-subjects, double-blind, randomised, placebo-controlled study (n=25) investigated the effects of MDMA (100mg) on brain connectivity, and found that it decreased functional connectivity insula/salience network, which was also correlated with baseline trait anxiety and acute experiences of altered bodily sensations under MDMA.
Authors
- Robin Carhart-Harris
- David Nutt
- Leor Roseman
Published
Abstract
Introduction
Recent work with noninvasive human brain imaging has started to investigate the effects of 3,4-methylenedioxymethamphetamine (MDMA) on large-scale patterns of brain activity. MDMA, a potent monoamine-releaser with particularly pronounced serotonin-releasing properties, has unique subjective effects that include: marked positive mood, pleasant/unusual bodily sensations and pro-social, empathic feelings. However, the neurobiological basis for these effects is not properly understood, and the present analysis sought to address this knowledge gap.
Methods
To do this, we administered MDMA-HCl (100 mg p.o.) and, separately, placebo (ascorbic acid) in a randomized, double-blind, repeated-measures design with twenty-five healthy volunteers undergoing fMRI scanning. We then employed a measure of global resting-state functional brain connectivity and follow-up seed-to-voxel analysis to the fMRI data we acquired.
Results
There was decreased right insula/salience network functional connectivity under MDMA. Furthermore, these decreases in right insula/salience network connectivity correlated with baseline trait anxiety and acute experiences of altered bodily sensations under MDMA.
Discussion
The present findings highlight insular disintegration (ie, compromised salience network membership) as a neurobiological signature of the MDMA experience, and relate this brain effect to trait anxiety and acutely altered bodily sensations-both of which are known to be associated with insular functioning.
Research Summary of 'Altered insula connectivity under MDMA'
Introduction
MDMA (3,4-methylenedioxymethamphetamine) is described as an entactogen with stimulant- and psychedelic-like properties, notable for pronounced serotonin release and subjective effects that include elevated mood, pro-social feelings and unusual bodily sensations. Previous neuroimaging work using PET, EEG and fMRI has reported MDMA-related decreases in regional cerebral blood flow and changes in connectivity in medial temporal and limbic structures; converging evidence has also implicated the insula in interoception and anxiety, and prior PET work reported insular blood-flow decreases after MDMA. However, earlier resting-state functional connectivity (RSFC) studies of MDMA have not specifically examined salience-network membership or insula-centred network integrity, partly because of methodological choices such as seed selection or independent component approaches that did not target the salience network directly. Walpola and colleagues therefore re-analysed an existing within-subjects, double-blind, placebo-controlled resting-state fMRI data set to test the hypothesis that MDMA acutely alters insula connectivity and salience-network integrity. The primary aim was to use a data‑driven voxelwise metric, the Intrinsic Connectivity Contrast (ICC), to identify regions with altered whole-brain connectivity under MDMA and then interrogate those regions with conventional seed-to-voxel and ROI-to-ROI analyses. The authors also examined whether MDMA-induced changes in insula connectivity related to baseline trait anxiety and reports of unusual bodily sensations as a proxy for altered interoception.
Expert Research Summaries
Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.
Full Text PDF
Full Paper PDF
Create a free account to open full-text PDFs.
Study Details
- Study Typeindividual
- Journal
- Compound
- Topics
- Authors
- APA Citation
Walpola, I. C., Nest, T., Roseman, L., Erritzoe, D., Feilding, A., Nutt, D. J., & Carhart-Harris, R. L. (2017). Altered insula connectivity under MDMA. Neuropsychopharmacology, 42(11), 2152-2162. https://doi.org/10.1038/npp.2017.35
References (8)
Papers cited by this study that are also in Blossom
Amoroso, T., Workman, M. · Journal of Psychopharmacology (2016)
Bedi, G., Cecchi, G. A., Slezak, D. F. et al. · Neuropsychopharmacology (2014)
´dric, C., Hysek, M., Schmid, Y. et al. · Social Cognitive and Affective Neuroscience (2013)
Liechti, M. E., Baumann, C., Gamma, A. et al. · Neuropsychopharmacology (2000)
Mithoefer, M. C., Wagner, M. T., Mithoefer, A. T. et al. · Journal of Psychopharmacology (2010)
Nichols, D. E. · Journal of Psychoactive Drugs (1986)
Oehen, P., Traber, R., Widmer, V. et al. · Journal of Psychopharmacology (2012)
Roseman, L., Leech, R., Feilding, A. et al. · Frontiers in Human Neuroscience (2014)
Cited By (8)
Papers in Blossom that reference this study
Ertl, N., Ashraf, I., Azizi, L. et al. · Biorxiv (2025)
Copa, D., Erritzoe, D., Giribaldi, B. et al. · Journal of Affective Disorders (2024)
Singleton, S. P., Wang, J. B., Mithoefer, A. T. et al. · Frontiers in Psychiatry (2023)
Aharon-Almagor, A., Barrett, F. S. · Research Square (2022)
Wolfson, P. E., Andries, J., Feduccia, A. A. et al. · Scientific Reports (2020)
Dipasquale, O., Selvaggi, P., Veronese, M. et al. · NeuroImage (2019)
Ot'alora G, M., Grigsby, J., Poulter, B. et al. · Journal of Psychopharmacology (2018)
Feduccia, A. A., Mithoefer, M. C. · Progress in Neuro-Psychopharmacology and Biological Psychiatry (2018)
Your Personal Research Library
Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.